New hope for ALS patients: experimental drug aims to slow devastating disease

NCT ID NCT05407324

Recruiting now Disease control Sponsor: Corcept Therapeutics Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational drug called dazucorilant is safe and can help slow the progression of ALS (amyotrophic lateral sclerosis). It will involve about 279 adults with ALS across North America and Europe. The main goal is to see if the drug can help patients maintain their physical abilities over 24 weeks compared to a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

062
RECRUITING

Phoenix, Arizona, 85013, United States
108
ACTIVE_NOT_RECRUITING

Leuven, 3000, Belgium
115
ACTIVE_NOT_RECRUITING

Barcelona, 08035, Spain
194
ACTIVE_NOT_RECRUITING

Valencia, 46026, Spain
253
ACTIVE_NOT_RECRUITING

Dublin, D09 YD60, Ireland
254
ACTIVE_NOT_RECRUITING

Warsaw, 01-684, Poland
255
ACTIVE_NOT_RECRUITING

Berlin, 13353, Germany
256
ACTIVE_NOT_RECRUITING

Tours, 37000, France
257
ACTIVE_NOT_RECRUITING

Limoges, 87042, France
258
ACTIVE_NOT_RECRUITING

Lille, 59037, France
259
ACTIVE_NOT_RECRUITING

Nice, 06001, France
260
ACTIVE_NOT_RECRUITING

Hanover, 30625, Germany
261
ACTIVE_NOT_RECRUITING

Marseille, 13385, France
262
ACTIVE_NOT_RECRUITING

Paris, 75651, France
263
ACTIVE_NOT_RECRUITING

Stoke-on-Trent, ST4 6QG, United Kingdom
264
ACTIVE_NOT_RECRUITING

Utrecht, 3584 CW, Netherlands
265
ACTIVE_NOT_RECRUITING

Jena, 7747, Germany
267
ACTIVE_NOT_RECRUITING

Rostock, 18147, Germany
268
ACTIVE_NOT_RECRUITING

Dresden, 1307, Germany
269
ACTIVE_NOT_RECRUITING

Ulm, 89081, Germany
270
ACTIVE_NOT_RECRUITING

Bonn, 53127, Germany
273
ACTIVE_NOT_RECRUITING

Montreal, Quebec, H3A2B4, Canada
274
ACTIVE_NOT_RECRUITING

Warsaw, 02-473, Poland
278
RECRUITING

San Francisco, California, 94109, United States
282
ACTIVE_NOT_RECRUITING

Málaga, 29010, Spain
283
ACTIVE_NOT_RECRUITING

Bydgoszcz, 85-163, Poland
287
RECRUITING

Neptune City, New Jersey, 07753, United States
302
ACTIVE_NOT_RECRUITING

Barcelona, 08003, Spain
303
ACTIVE_NOT_RECRUITING

Madrid, 28046, Spain
353
ACTIVE_NOT_RECRUITING

New York, New York, 10032, United States
385
ACTIVE_NOT_RECRUITING

Krakow, 30721, Poland
386
ACTIVE_NOT_RECRUITING

München, 81675, Germany
422
ACTIVE_NOT_RECRUITING

Bron, 69500, France
423
ACTIVE_NOT_RECRUITING

Montpellier, 42395, France
425
ACTIVE_NOT_RECRUITING

Hamilton, Ontario, L8N 3Z5, Canada

Conditions

Explore the condition pages connected to this study.

AMYOTROPHIC LATERAL SCLEROSIS